Scholar Rock (NASDAQ:SRRK) Hits New 1-Year High – What’s Next?

Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) reached a new 52-week high during mid-day trading on Friday . The company traded as high as $48.28 and last traded at $46.2020, with a volume of 77686 shares trading hands. The stock had previously closed at $47.76.

Wall Street Analysts Forecast Growth

SRRK has been the topic of several research analyst reports. Truist Financial lowered their price objective on shares of Scholar Rock from $54.00 to $44.00 and set a “buy” rating on the stock in a research report on Monday, October 20th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Scholar Rock in a research report on Thursday. Wolfe Research began coverage on Scholar Rock in a report on Tuesday, November 18th. They set an “outperform” rating and a $42.00 price target on the stock. Bank of America assumed coverage on Scholar Rock in a research note on Thursday, October 9th. They issued a “buy” rating and a $53.00 price objective for the company. Finally, UBS Group assumed coverage on Scholar Rock in a research report on Wednesday, January 7th. They set a “buy” rating and a $60.00 price objective for the company. Four investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $50.14.

Scholar Rock Stock Down 7.3%

The company has a debt-to-equity ratio of 0.41, a current ratio of 6.30 and a quick ratio of 6.30. The business has a 50 day simple moving average of $43.73 and a 200 day simple moving average of $37.32. The stock has a market cap of $4.52 billion, a PE ratio of -14.06 and a beta of 0.63.

Scholar Rock (NASDAQ:SRRK) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.90) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.88) by ($0.02). During the same quarter last year, the business posted ($0.66) earnings per share. On average, equities research analysts forecast that Scholar Rock Holding Corporation will post -2.42 EPS for the current fiscal year.

Insider Buying and Selling

In other news, General Counsel Junlin Ho sold 8,016 shares of the stock in a transaction on Friday, January 16th. The shares were sold at an average price of $44.48, for a total transaction of $356,551.68. Following the transaction, the general counsel owned 214,553 shares in the company, valued at $9,543,317.44. This represents a 3.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Mo Qatanani sold 14,898 shares of the company’s stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $46.71, for a total transaction of $695,885.58. Following the completion of the sale, the insider owned 85,660 shares of the company’s stock, valued at $4,001,178.60. This represents a 14.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 305,687 shares of company stock valued at $13,540,573. 13.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Three Seasons Wealth LLC boosted its stake in Scholar Rock by 2.1% in the 4th quarter. Three Seasons Wealth LLC now owns 10,968 shares of the company’s stock valued at $483,000 after buying an additional 222 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Scholar Rock by 7.9% during the third quarter. Principal Financial Group Inc. now owns 6,214 shares of the company’s stock valued at $231,000 after acquiring an additional 456 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Scholar Rock by 15.8% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,668 shares of the company’s stock valued at $130,000 after acquiring an additional 500 shares during the period. California State Teachers Retirement System boosted its stake in shares of Scholar Rock by 0.9% in the 2nd quarter. California State Teachers Retirement System now owns 62,372 shares of the company’s stock valued at $2,209,000 after purchasing an additional 577 shares in the last quarter. Finally, Tema Etfs LLC grew its holdings in shares of Scholar Rock by 6.6% in the 4th quarter. Tema Etfs LLC now owns 9,899 shares of the company’s stock worth $436,000 after purchasing an additional 616 shares during the last quarter. Institutional investors own 91.08% of the company’s stock.

Scholar Rock Company Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).